Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q3 2017 · 10-Q
Revenue—
Net Income-$1.63M-$1.63MN/M vs Q3 2016 EPS Diluted-$0.33-$0.33N/M vs Q3 2016 Operating Income-$1,333,421N/M Operating Cash Flowderived-$1,418,851N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Sep 30, 2017 · filed Nov 13, 2017 · 44 d after period end